The Roles of the Epithelial-Mesenchymal Transition Marker PRRX1 and miR-146b-5p in Papillary Thyroid Carcinoma Progression
Open Access
- 16 June 2014
- journal article
- Published by Elsevier BV in The American Journal of Pathology
- Vol. 184 (8), 2342-2354
- https://doi.org/10.1016/j.ajpath.2014.04.011
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- Prognostic Implications of miR-146b Expression and Its Functional Role in Papillary Thyroid CarcinomaJournal of Clinical Endocrinology & Metabolism, 2013
- The Prrx1 homeodomain transcription factor plays a central role in pancreatic regeneration and carcinogenesisGenes & Development, 2013
- Expression of epithelial-mesenchymal transition regulators SNAI2 and TWIST1 in thyroid carcinomasLaboratory Investigation, 2012
- Growth factor TGF-β induces intestinal epithelial cell (IEC-6) differentiation: miR-146b as a regulatory component in the negative feedback loopGenes & Nutrition, 2012
- Emerging Functions of microRNA-146a/b in Development and Breast CancerJournal of Mammary Gland Biology and Neoplasia, 2012
- The Emerging Cell Biology of Thyroid Stem CellsJournal of Clinical Endocrinology & Metabolism, 2011
- Identification of an adult stem/progenitor cell-like population in the human thyroidJournal of Endocrinology, 2008
- Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?Nature Reviews Cancer, 2007
- Gene expression and functional evidence of epithelial-to-mesenchymal transition in papillary thyroid carcinoma invasionProceedings of the National Academy of Sciences of the United States of America, 2007
- Raf-1 activation suppresses neuroendocrine marker and hormone levels in human gastrointestinal carcinoid cellsAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2003